From the Cancer Skin Care Program and SERIES Clinic, Department of Dermatology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Ill.
Financial Disclosure: Mario E. Lacouture, MD, is on the speaker bureau for Abbott Laboratories; Genentech, Inc.; ImClone Systems Incorporated; OSI Pharmaceuticals; and Onyx Pharmaceuticals, Inc. He is a consultant for Amgen, Bayer Healthcare Corporation, GlaxoSmithKline, and Bristol-Myers Squibb Company.
This educational activity was supported by an educational grant from Bristol-Myers Squibb Company & ImClone Systems Incorporated.
Corresponding author: Mario E. Lacouture, MD, Cancer Skin Care Program and SERIES Clinic, Department of Dermatology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 676 North St Clair Suite 1600, Chicago, IL 60611-2941 (e-mail: [email protected]).
Accepted for publication April 13, 2007.
